Literature DB >> 14663148

Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy.

Sam Holmstrom1, Mary E Van Antwerp, Jorge A Iñiguez-Lluhi.   

Abstract

Functional interactions between factors bound at multiple sites on DNA often lead to a synergistic or more-than-additive transcriptional response. We previously defined a class of peptide sequences termed synergy control motifs (SC motifs) that function in multiple regulators by selectively inhibiting synergistic activity driven from multiple but not single response elements. By studying the prototypic SC motifs of the glucocorticoid receptor, we show that SC motifs inhibit transcription per se both in cis and in trans, and that a requirement for multiple contacts with DNA renders them selective for compound response elements. Notably, SC motifs are sites for SUMOylation, and the degree of modification correlates strongly with the extent of synergy control. Recruiting SUMO to the promoter either independently or as a fusion to the glucocorticoid receptor is sufficient to recapitulate the in trans and in cis inhibition by SC motifs without apparent changes in subcellular localization. Moreover, we find that the core ubiquitin fold domain of SUMO is sufficient for inhibition and that, independently of their potential for polySUMO chain formation, SUMO-2 and SUMO-3 are more effective inhibitors than SUMO-1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14663148      PMCID: PMC307641          DOI: 10.1073/pnas.2136933100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Significance of mutations in the androgen receptor gene in males with idiopathic infertility.

Authors:  O Hiort; P M Holterhus; T Horter; W Schulze; B Kremke; M Bals-Pratsch; G H Sinnecker; K Kruse
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

2.  Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).

Authors:  H Poukka; U Karvonen; O A Janne; J J Palvimo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

3.  Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3.

Authors:  H Saitoh; J Hinchey
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

4.  Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity.

Authors:  Juraj Bies; Ján Markus; Linda Wolff
Journal:  J Biol Chem       Date:  2002-01-04       Impact factor: 5.157

5.  Androgen receptor-interacting protein 3 and other PIAS proteins cooperate with glucocorticoid receptor-interacting protein 1 in steroid receptor-dependent signaling.

Authors:  Noora Kotaja; Marianne Vihinen; Jorma J Palvimo; Olli A Jänne
Journal:  J Biol Chem       Date:  2002-03-13       Impact factor: 5.157

6.  Transcriptional activity of CCAAT/enhancer-binding proteins is controlled by a conserved inhibitory domain that is a target for sumoylation.

Authors:  Jinyong Kim; Carrie A Cantwell; Peter F Johnson; Curt M Pfarr; Simon C Williams
Journal:  J Biol Chem       Date:  2002-08-02       Impact factor: 5.157

7.  Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor.

Authors:  Sha Tian; Hetti Poukka; Jorma J Palvimo; Olli A Jänne
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

8.  Transcription factor Sp3 is silenced through SUMO modification by PIAS1.

Authors:  Alexandra Sapetschnig; Grigore Rischitor; Harald Braun; Andreas Doll; Marion Schergaut; Frauke Melchior; Guntram Suske
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

9.  Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition.

Authors:  Randy K Bledsoe; Valerie G Montana; Thomas B Stanley; Chris J Delves; Christopher J Apolito; David D McKee; Thomas G Consler; Derek J Parks; Eugene L Stewart; Timothy M Willson; Millard H Lambert; John T Moore; Kenneth H Pearce; H Eric Xu
Journal:  Cell       Date:  2002-07-12       Impact factor: 41.582

10.  Potentiation of glucocorticoid receptor transcriptional activity by sumoylation.

Authors:  Yves Le Drean; Nathalie Mincheneau; Pascale Le Goff; Denis Michel
Journal:  Endocrinology       Date:  2002-09       Impact factor: 4.736

View more
  64 in total

1.  Sumoylation of heterogeneous nuclear ribonucleoproteins, zinc finger proteins, and nuclear pore complex proteins: a proteomic analysis.

Authors:  Tianwei Li; Evgenij Evdokimov; Rong-Fong Shen; Chien-Chung Chao; Ephrem Tekle; Tao Wang; Earl R Stadtman; David C H Yang; P Boon Chock
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-25       Impact factor: 11.205

Review 2.  CHD chromatin remodelers and the transcription cycle.

Authors:  Magdalena Murawska; Alexander Brehm
Journal:  Transcription       Date:  2011-11-01

3.  Small ubiquitin-like modifier (SUMO) modification mediates function of the inhibitory domains of developmental regulators FOXC1 and FOXC2.

Authors:  Theodora E Danciu; Sergey Chupreta; Osvaldo Cruz; Jennifer E Fox; Malcolm Whitman; Jorge A Iñiguez-Lluhí
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

4.  SUMO functions in constitutive transcription and during activation of inducible genes in yeast.

Authors:  Emanuel Rosonina; Sarah M Duncan; James L Manley
Journal:  Genes Dev       Date:  2010-05-26       Impact factor: 11.361

5.  Mapping residues of SUMO precursors essential in differential maturation by SUMO-specific protease, SENP1.

Authors:  Zheng Xu; Shannon W N Au
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

6.  A small conserved surface in SUMO is the critical structural determinant of its transcriptional inhibitory properties.

Authors:  Sergey Chupreta; Sam Holmstrom; Lalitha Subramanian; Jorge A Iñiguez-Lluhí
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

7.  Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner.

Authors:  Hideki Murakami; Heinz Arnheiter
Journal:  Pigment Cell Res       Date:  2005-08

8.  Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.

Authors:  Serge Grégoire; Xiang-Jiao Yang
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

9.  SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.

Authors:  An-Jing Chen; Lu Gao; Xian-Wei Wang; Xiao-Fan Zhao; Jin-Xing Wang
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

10.  SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.

Authors:  Sam R Holmstrom; Sergey Chupreta; Alex Yick-Lun So; Jorge A Iñiguez-Lluhí
Journal:  Mol Endocrinol       Date:  2008-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.